BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25091936)

  • 1. Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei.
    Badejo JA; Abiodun OO; Akinola O; Happi CT; Sowunmi A; Gbotosho GO
    Malar J; 2014 Aug; 13():299. PubMed ID: 25091936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xylopic acid-amodiaquine and xylopic acid-artesunate combinations are effective in managing malaria in Plasmodium berghei-infected mice.
    Osei SA; Biney RP; Obese E; Agbenyeku MA; Attah IY; Ameyaw EO; Boampong JN
    Malar J; 2021 Feb; 20(1):113. PubMed ID: 33632233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lopinavir/ritonavir enhanced the antimalarial activity of amodiaquine and artesunate in a mouse model of Plasmodium berghei.
    Abiodun OO; Gbimadee N; Gbotosho GO
    J Chemother; 2016 Dec; 28(6):482-486. PubMed ID: 26900802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amodiaquine-Ciprofloxacin: a potential combination therapy against drug resistant malaria.
    Falajiki YF; Akinola O; Abiodun OO; Happi CT; Sowunmi A; Gbotosho GO
    Parasitology; 2015 May; 142(6):849-54. PubMed ID: 25736371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of herbal antimalarial MAMA decoction-amodiaquine combination in murine malaria model.
    Adepiti AO; Elujoba AA; Bolaji OO
    Pharm Biol; 2016 Oct; 54(10):2298-303. PubMed ID: 27057621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana.
    Abuaku B; Duah N; Quaye L; Quashie N; Malm K; Bart-Plange C; Koram K
    Malar J; 2016 Jan; 15():6. PubMed ID: 26728096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
    Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
    Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The blood schizontocidal effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on mice infected with Plasmodium berghei].
    Ye XY; Shao BR; Chu YH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(2):120-3. PubMed ID: 1394908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
    Whegang SY; Tahar R; Foumane VN; Soula G; Gwét H; Thalabard JC; Basco LK
    Malar J; 2010 Feb; 9():56. PubMed ID: 20170477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
    Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
    BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the combination of Uvaria chamae (P. Beauv.) and amodiaquine in murine malaria.
    Adepiti AO; Iwalewa EO
    J Ethnopharmacol; 2016 Dec; 193():30-35. PubMed ID: 27416806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
    Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
    Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.